Transparency Directive - Voting Rights and Capital The following notification is made in accordance with the UK Financial Services Authority Disclosure and Transparency Rule 5.6.1. On 27 February 2009 the issued share capital of AstraZeneca PLC with voting rights is 1,447,644,517 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,447,644,517. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the FSA's Disclosure and Transparency Rules. A C N Kemp Company Secretary 27 February 2009
Transparency Directive - Voting Rights and Capital
| Source: AstraZeneca PLC